Published in Cancer Weekly, August 4th, 2009
"We describe the partnership's effort to document the prevalence of lifetime and routine Papanicolau test use using community-based participatory research methods....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.